5,014 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
TNK or KEX: Which Is the Better Value Stock Right Now? https://www.zacks.com/stock/news/2242930/tnk-or-kex-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2242930 Mar 19, 2024 - TNK vs. KEX: Which Stock Is the Better Value Option?
Cognizant (CTSH) Partners NVIDIA to Boost Life Sciences Footprint https://www.zacks.com/stock/news/2242903/cognizant-ctsh-partners-nvidia-to-boost-life-sciences-footprint?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2242903 Mar 19, 2024 - Cognizant (CTSH) is strengthening its footprint in the life sciences and healthcare domain, driven by an expanding partner base that includes the likes of NVIDIA and Microsoft.
4 Reasons to Invest in Interactive Brokers (IBKR) Stock Now https://www.zacks.com/stock/news/2242971/4-reasons-to-invest-in-interactive-brokers-ibkr-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242971 Mar 19, 2024 - Supported by strong fundamentals and good growth prospects, Interactive Brokers (IBKR) stock looks like an attractive investment option now.
5 Reasons to Invest in T. Rowe Price (TROW) Stock Right Now https://www.zacks.com/stock/news/2242974/5-reasons-to-invest-in-t-rowe-price-trow-stock-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242974 Mar 19, 2024 - T. Rowe Price's (TROW) solid AUM balance, business diversification initiatives, acquisitions and global reach make it an attractive investment option.
These 2 Magnificent Stocks Are Soaring in 2024. This 1 Must-Know Trait Makes Them Smart Buys Right Now. https://www.fool.com/investing/2024/03/19/2-magnificent-stocks-soaring-2024-smart-buys/?source=iedfolrf0000001 Mar 19, 2024 - When looking for long-term stock ideas, investors might want to start identifying businesses that possess network effects.
DON: Monthly Dividend ETF We Are Avoiding For Now https://seekingalpha.com/article/4679125-don-monthly-dividend-etf-you-should-avoid?source=feed_tag_etf_portfolio_strategy Mar 19, 2024 - WisdomTree U.S. MidCap Dividend Fund ETF can be used to complement mid-cap value or dividend oriented portfolios. See why we think DON fund is an avoid.
Here's Why You Should Retain HealthEquity (HQY) Stock Now https://www.zacks.com/stock/news/2242869/here-s-why-you-should-retain-healthequity-hqy-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242869 Mar 19, 2024 - HealthEquity's (HQY) strength in HSAs raises optimism about the stock.
Reasons to Add Textron (TXT) Stock to Your Portfolio Now https://www.zacks.com/stock/news/2242860/reasons-to-add-textron-txt-stock-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242860 Mar 19, 2024 - Textron (TXT) makes a strong case for investment in the Aerospace Defense space, given its growth prospects, rising backlog and capital expenditure.
Indivior PLC (INDV) Could Find a Support Soon, Here's Why You Should Buy the Stock Now https://www.zacks.com/stock/news/2242851/indivior-plc-indv-could-find-a-support-soon-here-s-why-you-should-buy-the-stock-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2242851 Mar 19, 2024 - Indivior PLC (INDV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Arcutis Biotherapeutics, Inc. (ARQT) Could Find a Support Soon, Here's Why You Should Buy the Stock Now https://www.zacks.com/stock/news/2242852/arcutis-biotherapeutics-inc-arqt-could-find-a-support-soon-here-s-why-you-should-buy-the-stock-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2242852 Mar 19, 2024 - Arcutis Biotherapeutics, Inc. (ARQT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
<<<Page 333>